Oxford Global’s Cell & Gene Therapy Manufacturing and Supply Chain Congress aim to address key bottlenecks within the supply and manufacture of cell and gene therapies globally. Taking place on the 10-11th May 2023, Ireland Dublin, the event aims to bring together key industry leaders in Ireland the hub of cell and gene therapy manufacturing investment. 

Hear case studies on the cell and gene therapy landscape in Ireland, and the development of new manufacturing facilities. Presentations will showcase both viral and non-viral vector engineering and the acceleration of analytical tools and techniques to speed up process development, as well as streamlining CGT manufacture. 

Connect with over 150 attendees and benefit from 20+ presentations and interactive sessions covering the sustainability and automation of supply chains. Engage in valuable discussion on meeting regulatory requirements and solving CMC challenges to improve process development. 

Key Speakers include:

• Sarah Thomas, Senior Vice President, Quality, Regenixbio  
• Guy McDonell, Senior Director, Global Technology & Engineering, Pfizer  
• Kenneth Green, Senior Director, Vertex Pharmaceuticals 
• Shilpi Rajoria, Director QC Analytical Testing, Bristol Myers Squibb 
• Darrin Morrissey, Chief Executive Officer, National Institute for Bioprocessing Research & Training 

Engage in solution-oriented dialogue with 15+ vendor companies over 2-days over multiple networking breaks with the opportunity to meet 1-2-1 and eliminate the challenges you face.   

Do not miss this opportunity to engage with like-minded peers in the heart of Ireland to further your understanding of the cell and gene manufacturing. For more information, please contact h.liddiard@oxfordglobal.co.uk.